Literature DB >> 6352507

Antibodies against an acid extract from a single campylobacter strain in hospitalized campylobacter patients.

T U Kosunen, H Rautelin, T Pitkänen, A Pönkä, T Pettersson.   

Abstract

An acid glycine extract from a single Campylobacter jejuni strain was used as the antigen in the enzyme immunoassay (EIA). Elevated values indicating the presence of specific IgM and/or IgG antibodies were found in 73% of 52 patients hospitalized for campylobacter infection. A further 6% of the patients who had lower EIA values in paired serum samples showed at least a 20% change in EIA values. The same sera had been studied earlier for agglutinating antibodies using four reference campylobacter strains. 74% of the patients had shown elevated titres and a further 17% four-fold changes of lower titres in paired sera.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352507     DOI: 10.1007/bf01641193

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

1.  Campylobacter enteritis: a "new" disease.

Authors:  M B Skirrow
Journal:  Br Med J       Date:  1977-07-02

2.  Campylobacter serotyping a epidemiology.

Authors:  S Lauwers; L Vlaes; J P Butzler
Journal:  Lancet       Date:  1981-01-17       Impact factor: 79.321

3.  Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens.

Authors:  J L Penner; J N Hennessy
Journal:  J Clin Microbiol       Date:  1980-12       Impact factor: 5.948

4.  Serological response to Campylobacter jejuni/coli infection.

Authors:  D M Jones; J Eldridge; B Dale
Journal:  J Clin Pathol       Date:  1980-08       Impact factor: 3.411

5.  Clinical and serological studies in patients with Campylobacter fetus ssp. jejuni infection: II. Serological findings.

Authors:  T U Kosunen; T Pitkänen; T Pettersson; A Pönkä
Journal:  Infection       Date:  1981       Impact factor: 3.553

6.  Campylobacter enteritis: clinical and epidemiologic features.

Authors:  M J Blaser; I D Berkowitz; F M LaForce; J Cravens; L B Reller; W L Wang
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

7.  Campylobacter enteritis in children.

Authors:  M A Karmali; P C Fleming
Journal:  J Pediatr       Date:  1979-04       Impact factor: 4.406

8.  Superficial antigens of Campylobacter (Vibrio) fetus: characterization of antiphagocytic component.

Authors:  E C McCoy; D Doyle; K Burda; L B Corbeil; A J Winter
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

9.  Serology of Campylobacter fetus ss. jejuni )"related" campylobacters). Demonstration of strain-specific and interstrain-related antigens by immunoelectrophoresis and co-agglutination.

Authors:  T U Kosunen; D Danielsson; J Kjellander
Journal:  Acta Pathol Microbiol Scand B       Date:  1980-08
  9 in total
  8 in total

1.  Western blot analysis of the human antibody response to Campylobacter jejuni cellular antigens during gastrointestinal infection.

Authors:  I Nachamkin; A M Hart
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

2.  Campylobacter etiology in human gastroenteritis demonstrated by antibodies to acid extract antigen.

Authors:  H I Rautelin; T U Kosunen
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

3.  Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis.

Authors:  C Fendler; S Laitko; H Sörensen; C Gripenberg-Lerche; A Groh; J Uksila; K Granfors; J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

4.  Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis.

Authors:  T Yli-Kerttula; R Luukkainen; U Yli-Kerttula; T Möttönen; M Hakola; M Korpela; M Sanila; J Parviainen; J Uksila; R Vainionpää; A Toivanen
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

5.  Bacterial antibodies in ankylosing spondylitis.

Authors:  O Mäki-Ikola; K Lehtinen; K Granfors; R Vainionpää; P Toivanen
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

6.  Antibodies to arthritis-associated microbes in inflammatory joint diseases.

Authors:  O Mäki-Ikola; M K Viljanen; S Tiitinen; P Toivanen; K Granfors
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

7.  Analysis of Campylobacter jejuni antigens with monoclonal antibodies.

Authors:  T U Kosunen; B E Bång; M Hurme
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

Review 8.  A review of serological tests to assist diagnosis of reactive arthritis: critical appraisal on methodologies.

Authors:  Tamara Tuuminen; Kari Lounamo; Marjatta Leirisalo-Repo
Journal:  Front Immunol       Date:  2013-12-04       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.